Magnus Ekström
101 – 110 of 210
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Minimal clinically important differences for Dyspnea-12 and MDP scores are similar at 2 weeks and 6 months : follow-up of a longitudinal clinical study
(
- Contribution to journal › Letter
- 2020
-
Mark
Breathlessness, Anxiety, Depression, and Function–The BAD-F Study : A Cross-Sectional and Population Prevalence Study in Adults
(
- Contribution to journal › Article
-
Mark
Controlled-Release Oxycodone vs. Placebo in the Treatment of Chronic Breathlessness—A Multisite Randomized Placebo Controlled Trial
(
- Contribution to journal › Article
-
Mark
Long-term follow-up of patients undergoing standardized bicycle exercise stress testing : new recommendations for grading of exercise capacity are clinically relevant
(
- Contribution to journal › Article
-
Mark
No excess harms from sustained-release morphine : A randomised placebo-controlled trial in chronic breathlessness
(
- Contribution to journal › Article
-
Mark
Regular, sustained-release morphine for chronic breathlessness : A multicentre, double-blind, randomised, placebo-controlled trial
(
- Contribution to journal › Article
-
Mark
Fan therapy is a treatment option for relieving of chronic breathlessness
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality : A nationwide cohort study of the global SABINA programme
(
- Contribution to journal › Article
-
Mark
Hypercapnia in advanced chronic obstructive pulmonary disease : A secondary analysis of the national emphysema treatment trial
(
- Contribution to journal › Article
-
Mark
Editorial : Respiratory problems
(
- Contribution to journal › Debate/Note/Editorial